Variable | β | HR | (95%CI) | p value |
---|---|---|---|---|
Univariate analysis | ||||
Use of ECMO in 2016 | 1.85 | 6.33 | (1.35–33.3) | 0.019 |
Baseline PaO2/FIO2Baseline PaO2/FIO2 | 0.05 | 1.05 | (0.98–1.11) | 0.15 |
Lowest PaO2/FIO2Lowest PaO2/FIO2 | 0.03 | 1.03 | (0.98–1.08) | 0.27 |
Highest PEEP (cmH2O) Highest PEEP (cmH2O) | − 0.07 | 0.93 | (0.85–1.02) | 0.12 |
Maximum SOFA score | − 0.15 | 0.86 | (0.76–0.96) | 0.010 |
Use of peramivir | 0.81 | 2.25 | (0.68–7.14) | 0.18 |
Use of oseltamivir | − 0.85 | 0.43 | (0.12–1.47) | 0.18 |
Use of APRV | − 0.36 | 0.70 | (0.18–2.63) | 0.60 |
Size of drainage cannula | − 0.16 | 0.85 | (0.43–1.69) | 0.65 |
Size of return cannula | 0.20 | 1.22 | (0.57–2.63) | 0.60 |
Multivariate analysis | ||||
Use of ECMO in 2016 | 1.98 | 7.25 | (1.35–33.3) | 0.021 |
Maximum SOFA score | − 0.21 | 0.81 | (0.69–0.95) | 0.011 |